Compare BridgeBio Pharma Inc (BBIO) vs Symbotic Inc (SYM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Symbotic Inc — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Symbotic Inc trades at $43.81 (market cap $5.40B). The key difference: BridgeBio Pharma Inc is far larger — about 3× Symbotic Inc's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Symbotic Inc nearer its low. Which is the better fit depends on your goals.
| BBIO | SYM | |
|---|---|---|
Market Cap | $16.27B | $5.40B |
Sector | Health | Technology |
52-Week High | $90.17 | $87.30 |
52-Week Low | $44.81 | $38.57 |
Enterprise Value | $17.82B | $3.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Symbotic Inc
Symbotic is an automation technology leader that provides an end-to-end, A.I.-powered robotic platform for large-scale warehouse operations. By utilizing untethered, high-speed autonomous bots and sophisticated vision systems, Symbotic transforms traditional distribution centers into high-density strategic assets. The company serves the world’s largest retailers and wholesalers—most notably Walmart—while expanding into 'Warehouse-as-a-Service' through its GreenBox joint venture to democratize advanced automation for smaller enterprises.
Read more on SYM →
